Viewing Study NCT01847118


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2026-02-26 @ 12:03 PM
Study NCT ID: NCT01847118
Status: UNKNOWN
Last Update Posted: 2015-03-24
First Post: 2013-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ia, Dose Escalation Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection in Patients With Advanced or Metastatic Solid Tumors
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module